§ Federal grant opportunity · HT942526BCRPBTA4
DoW Breast Cancer, Breakthrough Award Level 4
Jamie Shortall Grant Officer is accepting applications for DoW Breast Cancer, Breakthrough Award Level 4. The deadline is September 30, 2026 and the published award range is Award amount not published.
Key facts
- Funder
- Jamie Shortall Grant Officer
- Application deadline
- September 30, 2026
- Award range
- Award amount not published
- Eligibility
- Eligibility criteria are published in the funding opportunity announcement.
- Geography
- United States
- Focus areas
- Research
- Opportunity number
- HT942526BCRPBTA4
Program overview
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Breakthrough Award mechanism contains four different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level specifies a distinct research scope. This program announcement discusses the Breakthrough Award Level 4. Distinctive Features: · Clinical trials are required. · The research team must include two or more breast cancer consumer advocates. · This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from Jamie Shortall Grant Officer.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before September 30, 2026, allowing time for registration and validation.
Related grant opportunities
- DoW Amyotrophic Lateral Sclerosis Research Program, Pilot Clinical Trial Award
- DoW Breast Cancer, Transformative Breast Cancer Consortium Award
- DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award
- DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award
- DoW Breast Cancer, Breakthrough Award Level 3
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.